AMBBY (Ambu AS) ROCE %: 10.68% (As of Mar. 2026)


AMBBY Ambu AS AMBBY
84 GF Score
Price $9.43
GF Value $19.37
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS ROCE %?

Ambu AS AMBBY 84 ROCE % is 10.68% as of Mar. 2026. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.37 (Significantly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ambu AS's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.68%.

Ambu AS  (OTCPK:AMBBY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ambu AS ROCE % Related Terms

Ambu AS ROCE % Historical Data

* Premium members only.

The historical data trend for Ambu AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS ROCE % Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.72 2.41 4.69 5.55 12.78

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.57 11.17 9.44 10.30 10.68
AMBBY
84GF Score
Ambu AS AMBBY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS ROCE % Calculation

Ambu AS's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=123.447/( ( (1064.9 - 157.636) + (1206.951 - 182.261) )/ 2 )
=123.447/( (907.264+1024.69)/ 2 )
=123.447/965.977
=12.78 %

Ambu AS's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=108.888/( ( (1188.543 - 166.97) + (1176.434 - 159.621) )/ 2 )
=108.888/( ( 1021.573 + 1016.813 )/ 2 )
=108.888/1019.193
=10.68 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.68% mean?
Ambu AS (AMBBY) has a ROCE % of 10.68% as of Mar. 2026.
Is Ambu AS's ROCE % too high?
Ambu AS's current ROCE % is 10.68%. The Medical Devices & Instruments industry median ROCE % is 2.23. Ambu AS's value of 10.68% is 378.9% above this industry median. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's ROCE % compare to ABT and SYK?
Ambu AS's ROCE % of 10.68% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Ambu AS's value of 10.68% is 378.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current ROCE % of 10.68% is 378.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current ROCE % is 10.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.37, compared to a current price of $9.43 — trading 51.3% below its estimated fair value. The current ROCE % is 10.68% and 378.9% above the Medical Devices & Instruments industry median of 2.23. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ambu AS (AMBBY), the current ROCE % is 10.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (AMBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of $9.43 is trading 51.3% below its estimated GF Value™ of $19.37. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for AMBBY:

  • ROCE %: 10.68%
  • GF Value™: $19.37 vs. price of $9.43 (51.3% below fair value)
  • GF Score™: 84/100
  • Industry Position: 378.9% above the Medical Devices & Instruments median

No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score

Get the complete analysis for AMBBY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.43
Price
$19.37
GF Value